Stephens Inc. AR Sells 833 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Stephens Inc. AR decreased its position in Healthpeak Properties, Inc. (NYSE:DOC) by 5.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 13,280 shares of the real estate investment trust’s stock after selling 833 shares during the period. Stephens Inc. AR’s holdings in Healthpeak Properties were worth $269,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of DOC. JPMorgan Chase & Co. increased its position in Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after purchasing an additional 4,056,931 shares during the period. Thrivent Financial for Lutherans purchased a new position in Healthpeak Properties during the third quarter valued at approximately $1,880,000. Swedbank AB bought a new position in Healthpeak Properties in the third quarter worth approximately $1,832,000. Pathstone Holdings LLC purchased a new stake in Healthpeak Properties during the third quarter worth $1,968,000. Finally, Associated Banc Corp bought a new stake in Healthpeak Properties during the 3rd quarter valued at $10,559,000. Institutional investors own 93.57% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently weighed in on DOC. Wells Fargo & Company dropped their price objective on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $20.00 to $28.00 in a research report on Monday, October 21st. Royal Bank of Canada increased their target price on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Wedbush cut their price target on shares of Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday. Finally, Mizuho decreased their price objective on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $24.00.

Healthpeak Properties Trading Down 1.9 %

Shares of NYSE:DOC opened at $19.57 on Monday. The company has a current ratio of 1.35, a quick ratio of 1.31 and a debt-to-equity ratio of 0.96. Healthpeak Properties, Inc. has a 12-month low of $16.01 and a 12-month high of $23.26. The business has a 50 day moving average of $20.36 and a two-hundred day moving average of $21.45. The company has a market capitalization of $13.69 billion, a PE ratio of 55.92, a PEG ratio of 2.18 and a beta of 1.15.

Healthpeak Properties Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Friday, February 14th will be paid a $0.305 dividend. This is a boost from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a dividend yield of 6.23%. The ex-dividend date of this dividend is Friday, February 14th. Healthpeak Properties’s payout ratio is currently 342.87%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.